Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01514552 · ClinicalTrials.gov registry record · Phase 1

The Use of Functional Confections in Promoting Oral Health

A Phase 1 study of Oral Cancer and Oral Health, sponsored by Ohio State University.

Active
Registry status
Phase 1
Development phase
36
Enrollment target
1
Study location

NCT01514552: Active Phase 1 study of Oral Cancer and Oral Health, sponsored by Ohio State University.

NCT01514552 is a Phase 1 study of Oral Cancer and Oral Health that is active but no longer recruiting, run by Ohio State University. The registered enrollment target is 36 participants, below the 211-participant average among 17 other Oral Cancer trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01514552, a Phase 1 study of Oral Cancer and Oral Health, is active but no longer recruiting, sponsored by Ohio State University.

ACTIVE NOT RECRUITING
Registry status
Phase 1
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

In areas of the world where populations are undernourished poor oral health is prevalent. Diets rich in fruit and vegetables are thought to have many health benefits including reducing the risk of oral cancer or gum disease. In particular fruits such as strawberries contain many different compounds which may be responsible for these proposed health benefits. From this study, the researchers hope to gain information about how the tissues in the mouth absorb strawberry gummies in a population of habitually smoking and never smoking men and women. The researchers will measure inflammation hormones in your saliva and urine and the genes in your mouth and blood. Two different strawberry gummies will be tested in this study. The strawberry gummies were developed at OSU in the Department of Food Science and Technology. One type of strawberry gummy will contain freeze-dried whole strawberries while the other type will have no fruit. In total the eight pieces of strawberry gummies that you will consume in one day will be at most equal to 1 cup of whole strawberries. The research team believes the two strawberry gummies may be digested and absorbed differently and that components in the strawberry gummies may be helpful for oral health.

Primary Outcome

Daily records of consumption will be maintained. Standardized qualitative and quantitative toxicity criteria (NIH Common Terminology Criteria for Adverse Events, v. 3.0) will be employed to describe the safety as well as incidence toxicity

Interventions

  • OTHER Strawberry gummy
  • OTHER Placebo control gummy

Study Locations (1)

Ohio

  • The Ohio State University - Columbus

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2010-11
Est. Completion 2026-04-10
Phase Phase 1
Ohio State University

552 total trials

What the registry record for NCT01514552 still lists

NCT01514552 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 211-participant average among 17 other Oral Cancer trials with a reported enrollment target (83% lower).

The record links to 3 conditions, with Oral Cancer appearing as the primary indexed condition, and to 2 interventions - of which Strawberry gummy is the first listed.

NCT01514552 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT01514552 about?

NCT01514552 is a clinical study titled "The Use of Functional Confections in Promoting Oral Health". In areas of the world where populations are undernourished poor oral health is prevalent. Diets rich in fruit and vegetables are thought to have many health benefits including reducing the risk of oral cancer or gum disease. In particular fruits such as strawberries contain many different compounds ...

What is the current status of trial NCT01514552?

This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2010-11. Estimated completion is 2026-04-10.

What conditions does trial NCT01514552 study?

This clinical trial studies the following conditions: Oral Cancer, Oral Health, Gum Disease.

What interventions are being tested in trial NCT01514552?

The interventions under investigation include: Strawberry gummy (OTHER), Placebo control gummy (OTHER).

Who is sponsoring clinical trial NCT01514552?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01514552 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Oral Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01514552's enrollment target sits among peer trials

36 16th of 17 higher than 2 of 17 other Oral Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Oral Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00929006 · 36 participants · Early Phase 1

    Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism

  • NCT01891318 · 36 participants · Phase 1

    Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

  • NCT02291848 · 36 participants · Phase 1

    Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

  • NCT02366819 · 36 participants · Phase 4

    Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01514552, the US trial registry maintained by the National Library of Medicine. NCT01514552 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.